Grey Wolf Animal Health Corp. Share Price

Equities

WOLF

CA55910M1041

Other Specialty Retailers

End-of-day quote Toronto S.E. 23:00:00 13/05/2024 BST 5-day change 1st Jan Change
0.72 CAD -7.69% Intraday chart for Grey Wolf Animal Health Corp. -1.37% -2.70%

Financials

Sales 2022 22.64M 16.58M 1.32B Sales 2023 25.41M 18.61M 1.48B Capitalization 22.96M 16.82M 1.34B
Net income 2022 2M 1.46M 116M Net income 2023 - 0 0 EV / Sales 2022 1.25 x
Net Debt 2022 4.17M 3.05M 243M Net Debt 2023 2.14M 1.56M 124M EV / Sales 2023 0.99 x
P/E ratio 2022
5.12 x
P/E ratio 2023
37.7 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 85.88%
More Fundamentals * Assessed data
Dynamic Chart
1 day-7.69%
1 week-1.37%
Current month-7.69%
1 month-6.49%
3 months-20.00%
6 months+7.46%
Current year-2.70%
More quotes
1 week
0.72
Extreme 0.72
0.78
1 month
0.69
Extreme 0.69
0.80
Current year
0.68
Extreme 0.68
1.00
1 year
0.60
Extreme 0.6
1.00
3 years
0.60
Extreme 0.6
3.17
5 years
0.60
Extreme 0.6
3.17
10 years
0.60
Extreme 0.6
3.17
More quotes
Date Price Change Volume
14/05/24 0.72 -7.69% 14,500
10/05/24 0.78 +6.85% 2,500
09/05/24 0.73 0.00% 7,500
08/05/24 0.73 0.00% 1,000
07/05/24 0.73 -1.35% 3,500

End-of-day quote Toronto S.E., May 13, 2024

More quotes
Grey Wolf Animal Health Corp. is a Canada-based animal health and wellness company. It has a portfolio of products that meets the unmet needs of veterinarians, clinics, and pets. Its segments include the animal health business unit and the pharmacy business unit. The animal health business unit segment primarily focuses on selling, marketing, and distributing pharmaceutical, nutraceutical and consumable products to veterinary clinics across Canada. The pharmacy business unit segment compounds pharmaceuticals, primarily for equine use but also for the bioidentical hormone replacement therapy market, all based on prescriptions received from veterinarians, physicians, and patients. Its product categories include companion animals and equine health. The companion animals product category includes wound care, nutraceuticals, and others. It focuses on in-licensing, acquiring, or developing prescription and non-prescription products for commercialization in the veterinarian channel in Canada.
More about the company